HUM Stock Recent News
HUM LATEST HEADLINES
The health insurer has lost 24% in the week to data after it said the government is set to cut the rating on a large Medicare Advantage plan.
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Humana Inc. (NYSE: HUM) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Shares in Humana (HUM) will likely remain on watchlists after plummeting Wednesday to levels not seen in more than four years after the Centers for Medicare and Medicaid Services (CMS) downgraded a large portion of the health insurer's Medicare offerings.
The Law Offices of Frank R. Cruz Announces Investigation of Humana Inc. (HUM) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On October 2, 2024, Humana disclosed that it has “approximately 1.6 million, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, a reduction from 94% in.
Anthony Forcione, Rockland Trust VP, joins 'Power Lunch' to discuss stock plays for three stocks.
The best traders don't play offense. They play defense.
Shares of Humana Inc (HUM, Financial) fell 17.63% in mid-day trading on Oct 2. The stock reached an intraday low of $213.31, before recovering slightly to $230.18, down from its previous close of $279.45.
CNBC's Bertha Coombs joins 'Squawk on the Street' to discuss why Humana is plunging today.
Humana's stock was headed for another sharp selloff on Tuesday, toward a more than four-year low, after the government cut its rating on one of the health insurer's large Medicare Advantage plans because it missed some performance measures.
Humana said the total members enrolled in its highly rated Medicare Advantage plans for people aged 65 years and above have reduced for 2025, sending the insurer's shares down about 12% in premarket trading.